Wolverine Trading, LLC Protalix Bio Therapeutics, Inc. Transaction History
Wolverine Trading, LLC
- $96.9 Billion
- Q2 2025
A detailed history of Wolverine Trading, LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 24,508 shares of PLX stock, worth $58,819. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,508
Previous 11,700
109.47%
Holding current value
$58,819
Previous $29,000
24.14%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PLX
# of Institutions
69Shares Held
8.72MCall Options Held
168KPut Options Held
31.4K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.62MShares$3.88 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.08MShares$2.59 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA826KShares$1.98 Million0.0% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.496KShares$1.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA485KShares$1.16 Million0.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $119M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...